SCHEMBL22945671

SCHEMBL22945671

COc1cc(C(C)C)c(Cl)c(OC)c1C1CC1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.35
PIK3CD O00329 2/20 0.34
BCL9 O00512 1/20 0.34
CTNNB1 P35222 1/20 0.34
PTAFR P25105 2/20 0.33
THRB P10828 1/20 0.33
RORC P51449 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
GFER P55789 1/20 0.33
LPAR1 Q92633 2/20 0.32
P2RX3 P56373 1/20 0.32
P2RX2 Q9UBL9 1/20 0.32
PTPN1 P18031 1/20 0.32
ACHE P22303 1/20 0.32
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
PDE3B Q13370 2/20 0.31
PDE3A Q14432 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22945960 0.84 POLB (0.36) HTR2APIK3CDBCL9CTNNB1PTAFR
SCHEMBL21275892 0.77 ACHE (0.41) THRBRORCPOLBGAAGFER
SCHEMBL16133976 0.75 PDE3B (0.33) HTR2ABCL9CTNNB1GAALPAR1
SCHEMBL24371608 0.74 GAA (0.41) THRBRORCPOLBGAAGFER
SCHEMBL15713203 0.72 HDAC4 (0.42) BCL9CTNNB1
SCHEMBL28706178 0.71 TACR1 (0.37) POLBACHE
SCHEMBL16134106 0.70 POLB (0.35) HTR2APOLBGAAGFERPDE3B
SCHEMBL16071630 0.69 HTR1A (0.35) HTR2ABCL9CTNNB1PTAFRGAA
SCHEMBL20259973 0.69 POLB (0.40) HTR2ATHRBRORCPOLBGAA
SCHEMBL16059420 0.68 GAA (0.40) HTR2ABCL9CTNNB1GAACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4008405-A1 UREA COMPOUND FOR ANTAGONIZING LPA1 RECEPTOR Taisho Pharmaceutical Co., Ltd. (JP) 2022-06-08 EP disclosed
WO-2021020429-A1 UREA COMPOUND FOR ANTAGONIZING LPA1 RECEPTOR 大正製薬株式会社 2021-02-04 WO disclosed